Coverage
-
September 02, 2014
A Delaware federal judge on Friday found Novartis Pharmaceuticals Corp. hadn't shown Par Pharmaceutical Inc. infringed a patent for a patch that treats Alzheimer's disease, asking the generic-name drugmaker to file a draft of a final judgment in its favor in the consolidated suit.
2 other articles on this case.
View all »